Alison J. Rodger
Impact in
- Virology top 0.2%
- Poxvirus research and outbreaks
- HIV Research and Treatment
- Infectious Diseases top 0.1%
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS Research and Interventions 78
- SARS-CoV-2 and COVID-19 Research 12
- Virology 18
- HIV Research and Treatment 15
- Co-authors
- Andrew N. Phillips (63 shared papers)Fiona C. Lampe (61 shared papers)Nick Crofts (8 shared papers)Andrew Speakman (36 shared papers)Richard J.C. Gilson (28 shared papers)Nigel Field (8 shared papers)Valentina Cambiano (27 shared papers)Simon N Collins (28 shared papers)
- Journals
- HIV Medicine (14 papers)Sexually Transmitted Infections (12 papers)PLoS ONE (10 papers)AIDS (8 papers)The Lancet (8 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Alison J. Rodger
194 papers receiving 11.7k citations
Alison J. Rodger's Hit Papers
Peers
Comparison fields: 5 of 164
- Virology 2.0k
- Infectious Diseases 6.0k
- Hepatology 1.0k
- Epidemiology 3.5k
- Emergency Medicine 599
Countries citing papers authored by Alison J. Rodger
This map shows the geographic impact of Alison J. Rodger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Rodger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Rodger more than expected).
Fields of papers citing papers by Alison J. Rodger
This network shows the impact of papers produced by Alison J. Rodger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Rodger. The network helps show where Alison J. Rodger may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison J. Rodger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy Hit paper breakdown → | 2016 | 1089 |
| 2 | Clinical features and management of human monkeypox: a retrospective observational study in the UK Hit paper breakdown → | 2022 | 966 |
| 3 | Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth Hit paper breakdown → | 2019 | 793 |
| 4 | Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study Hit paper breakdown → | 2019 | 736 |
| 5 | COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study Hit paper breakdown → | 2021 | 577 |
| 6 | SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Hit paper breakdown → | 2021 | 443 |
| 7 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 8 | Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease Hit paper breakdown → | 2019 | 351 |
| 9 | Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population Hit paper breakdown → | 2012 | 305 |
| 10 | 2016 | 294 | |
| 11 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 12 | 2014 | 267 | |
| 13 | 2014 | 264 | |
| 14 | 1999 | 257 | |
| 15 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 16 | 2013 | 186 | |
| 17 | 2017 | 177 | |
| 18 | 2000 | 152 | |
| 19 | 2020 | 142 | |
| 20 | 2016 | 139 |
About Alison J. Rodger
Alison J. Rodger is a scholar working on Infectious Diseases, Virology, Epidemiology, Hepatology and Emergency Medicine, having authored 201 papers that have together received 12.0k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (78 papers), HIV, Drug Use, Sexual Risk (20 papers), Hepatitis C virus research (17 papers), HIV Research and Treatment (15 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Hepatitis B Virus Studies (12 papers), Sex work and related issues (10 papers) and Adolescent Sexual and Reproductive Health (8 papers). The work is most often cited by research in Virology (2.0k citations), Infectious Diseases (6.0k citations), Hepatology (1.0k citations), Epidemiology (3.5k citations) and Emergency Medicine (599 citations). Alison J. Rodger has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Andrew N. Phillips, Fiona C. Lampe, Nick Crofts, Andrew Speakman, Richard J.C. Gilson, Nigel Field, Valentina Cambiano, Simon N Collins, Anna Lanigan and Trevor D. Lawley. Their work appears in journals such as HIV Medicine, Sexually Transmitted Infections, PLoS ONE, AIDS and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.